SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study

    November 2020 in “ Journal of the European Academy of Dermatology and Venereology ”
    Óscar M. Moreno‐Arrones, Alejandro Lobato‐Berezo, Alba Gómez‐Zubiaur … Sergio Vañó‐Galván
    Studysummary This article discusses SARS-CoV-2-induced telogen effluvium in a multicentric study and reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pmc.ncbi.nlm.nih.gov →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign' Journal of The American Academy of Dermatology · 2020
    2. Covid-19 And Dermatology: A Comprehensive Guide For Dermatologists Journal of the European Academy of Dermatology and Venereology · 2020
    3. Hair Shedding in Women: How Much Is Too Much? British Journal of Dermatology · 2015
    4. Postfebrile Telogen Effluvium in Critically Ill Patients Critical Care Medicine · 1988

    Related research 1

    1. A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity Journal of Cosmetic Dermatology · 2020